Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection

Clinical trial NCT00117689 · COMPLETED

Trial details

NCT number: NCT00117689
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Dysfunction Rejection, Transplant Transplantation, Liver

Start date: 2005-04-01
Primary completion: 2007-12-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.